Harbor Investment Advisory’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
Other funds holding UTHR
ACA
JT
Harbor Investment Advisory's UTHR Position: Q2 2026 in Review
Harbor Investment Advisory held its United Therapeutics (UTHR) position steady in Q2 2026 at 614 shares worth $333K. The position accounts for 0.02% of the portfolio, ranked #348.
Harbor Investment Advisory first reported a position in UTHR in Q4 2019 and has held it in 27 quarters since. The position peaked at $364K in Q1 2026. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.
- Harbor Investment Advisory held 614 shares of United Therapeutics worth $333K as of Q2 2026.
- Harbor Investment Advisory left its United Therapeutics share count unchanged in Q2 2026.
- United Therapeutics made up 0.02% of Harbor Investment Advisory's portfolio in Q2 2026, its #348 holding.
- Harbor Investment Advisory first reported a position in United Therapeutics in Q4 2019 and has held it in 27 quarters since.
- Harbor Investment Advisory's United Therapeutics position peaked at $364K in Q1 2026.
- 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.
Based on Harbor Investment Advisory's 13F filing for Q2 2026, filed 7 Jul 2026.